SUMMARY Chronic (atrophic) gastritis (AG) is common in active duodenal (DU) and gastric ulcer (GU) disease. In this case control study in consecutive prospective outpatients (571 cases and 1074 controls) who had undergone diagnostic upper gastrointestinal endoscopy and routine biopsies from both antral and body mucosa, we calculated the risk of coexisting active DU and/or GU in different gastritis ofthe antrum or body and according to grade (superficial gastritis, mild, moderate or severe atrophic gastritis). The risk of coexisting active gastroduodenal ulcer (ulcer in duodenum and/or stomach), as well as the risk of DU or GU, was dependent upon the presence and grade of gastritis in antrum and body mucosa. The risk of coexisting ulcer, as expressed as an age adjusted relative risk (RR) and calculated as odds ratio of gastritis in cases and controls, was significantly increased in the presence of superficial antral and body gastritis (RR=8.5 (7'0-20 0) in men; RR=5.8 (33-10.2) in women), as compared with the risk of ulcer in subjects with histologically normal mucosa (RR=1). The risk of ulcer, and the risk of GU in particular, increased further with increasing severity of antral gastritis. In such patients with moderate or severe atrophic antral gastritis the RR of coexisting ulcer even exceeded 20 in men and 10 in women (RR=25.6 (9'0-72.7) in men; RR=11.7 (5.9-23.0) in women). On the other hand, the RR of ulcer, and the RR of DU in particular, was below 1 in the presence of atrophic gastritis in the gastric body, irrespective of the grade of gastritis in the antrum. We conclude that the type and grade of gastritis strongly predicts the risk of coexisting peptic ulcer, and that the risk of coexisting DU or GU increases with an increase in grade of AG of the antrum but decreases with an increase in grade of AG of the gastric body.
1 in the presence of atrophic gastritis in the gastric body, irrespective of the grade of gastritis in the antrum. We conclude that the type and grade of gastritis strongly predicts the risk of coexisting peptic ulcer, and that the risk of coexisting DU or GU increases with an increase in grade of AG of the antrum but decreases with an increase in grade of AG of the gastric body.
Chronic (atrophic) gastritis is common in active peptic ulcer disease. Antral gastritis occurs in 75-95% of patients with duodenal ulcer (DU) and nearly always in patients with gastric ulcer (GU).'-À lthough the causal relationship between gastritis and ulcer diseases is unclear and controversial, gastritis may play a role in the pathogenesis of DU and GU diseases and may impair the resistance of the gastric mucosa and consequently increase the risk of ulcer."' On the other hand, atrophic gastritis in the gastric body has a negative effect on acid and pepsin secretion, and may subsequently decrease the risk of subjects to contract an active ulcer." Gastritis is also common in the general population. It (1(X)) bulb; n=211) and 'gastric ulcer' (GU, ulcer in angular area or in gastric body; n= 186).
GASTRODUODENAL ULCER
The RRmh of coexisting gastroduodenal ulcer (all cases with ulcer either in duodenum and/or stomach) in the different grades of antral and body gastritis are presented in Tables 4 and 6 and in the Figure. In Tables 4 and 6 the mean risks are adjusted for age alone whereas in the Figure the data are also standardised to take account of coexisting antral gastritis in examining the risks associated with body gastritis, and vica versa.
In comparison with the risk of coexisting active ulcer in subjects with normal antral mucosa (RR= 1), the mean risk of gastroduodenal ulcer was highly significantly above the baseline level (RR= 1) in subjects who showed antral gastritis (Figure) . This risk was increased already in subjects with superficial antral gastritis (grade S; RRmh 9 7 (Figure) .
The influence of body gastritis on the ulcer risk was opposite to that of antral gastritis. The risk of coexisting ulcer decreased significantly and linearly with an increase in grade of body gastritis (Figure) : the mean RRmh'S of ulcer in men with superficial body gastritis (S) or with advanced atrophic body gastritis (A2-A3) were 1-4 (1P2-1.6) and 0-1 (0.04-0.4), respectively. The corresponding risks in women were 1-02 (1.01-1.03) and 0-6 (0-4-0 8) (Figure) .
The age adjusted RRmh'S of coexisting active ulcer in subjects with different combinations (phenotypes) of antral and body gastritis, in comparison with risk of ulcer in the presence of a normal stomach (phenotype N/N; RR= 1), are shown in Table 7 . The ulcer risk in both sexes was clearly and significantly increased in most of the phenotypes, although some important differences existed. We emphasise the following three observations (Table 7) .
First, the atrophic antral gastritis (A1-A3) that coexisted with non-atrophic body mucosa (N or S) was the phenotype in which the risk of ulcer was highest: the ulcer risk in subjects with phenotype Al-A3/S exceeded 20 for men and 10 for women. Second, irrespective of the grade of gastritis of the antrum, the presence of even mild atrophic gastritis (A1) in gastric body mucosa significantly decreased the risk of coexisting ulcer to levels that were indistinguishable from the baseline (RR=1). Third, in comparison with phenotype N/N, the risk of ulcer in all phenotypes of gastritis tended to be higher in men than women.
DUODENAL AND GASTRIC ULCER
The estimates for the age adjusted relative risks, separately for co-existing DU (active ulcer in duodenal bulb) or GU (active angular or high gastric ulcer), in patients with antral or body gastritis are presented in Tables 5 and 8 .
The risks of both DU and GU in both sexes were highly significantly higher in the presence of superficial gastritis (S) in the antrum than in the presence of histologically normal antrum (Table 8 ). There were, however, some differences between DU and GU.
First, with increase in grade of antral gastritis from S to A1-A3 the mean RRmh of coexisting GU greatly increased; this risk exceeded 30 in men and 20 in women if the patient had atrophic gastritis (A1-A3) in the antrum. The risk of coexisting DU did not show such a trend, however (Table 8) . Second, with increase in grade of chronic body gastritis from S to group.bmj.com on July 7, 2017 -Published by http://gut.bmj.com/ Downloaded from A1-A3 the risk of DU decreased significantly in both sexes below the baseline level (RR= 1), whereas the risk of GU was of same magnitude in both sexes in the presence of S or A1-A3 in the gastric body (Table 5) .
Discussion
The present calculations show that a strong association between chronic gastritis and active peptic ulcer exists. In the presence of gastritis, an active ulcer either in duodenum or stomach was several times more common than expected. Although DU and GU do not occur in fundamentally similar circumstances, both seem to show similar features in relation to gastritis. In comparison with subjects with histologically normal gastric mucosa, the risk and probability of coexisting ulcer was markedly and highly significantly increased in the presence of gastritis, this risk and probability being dependent on grade of gastritis in antrum and body. With regard to these risks, however, antral and body gastritis behaved opposite to each other: the risk of active ulcer rose linearly with an increase in grade of gastritis of the antral mucosa but decreased, again linearly, with an increase in grade of gastritis of the gastric body. The calculations showed that the risk of coexisting ulcer was highest in patients who had atrophic gastritis in the antrum and non-atrophic mucosa in the gastric body -that is, gastritis of the B type.2" Active DU or GU appeared over 20 times more common among men with gastritis of this B type than in subjects with histologically normal stomach.
The extremely common occurrence of gastritis in ulcer patients'-"'' and the high risk of coexisting active ulcer in gastritis may suggest that gastritis is causally related to both DU and GU, even though the possibility cannot be excluded that gastritis simply results from the ulcer itself. The present observations on 'dose-response' like relationship between grade of gastritis and general ulcer risk could be, however, considered to support the former possibility. In addition, this is suggested by earlier observations that the healing of ulcer is not accompanied by resolution of the gastritis.3 7" 2 21 Furthermore, GU typically develops in the stomach at the distal site of the antrofundal junction where the gastritic and atrophic alterations usually are most extensive.212' These findings may indirectly suggest that gastritis precedes and predisposes to ulcer rather than simply accompanies or follows it.
The negative relationship between active ulcer and body gastritis can be explained by a negative effect of gastritis on capability of the body mucosa to secrete acid and pepsins, and by a consequent decrease in probability of a subject to contract peptic ulcer. Inflammation and atrophy cause a loss of normal acid and pepsinogen secreting elements in the oxyntic mucosa. 2 The acid secretion capacity of the stomach is indeed linearly dependent upon the total mass of parietal cells and upon the number of normal oxyntic glands,2'1" and even a mild atrophic gastritis in the gastric body mucosa results in a significant reduction of both basal and stimulated acid secretion.'"
The opposite relation of atrophic antral and body gastrites to ulcer risks indicates that antral and body gastrites are independent risk factors. The of coexisting ulcer in patients with even mild body atrophy exceeded only slightly and insignificantly the level of the risk seen in subjects with histologically normal stomach. This strong influence of body atrophy on ulcer risk seems to concern DU in particular.
The present calculations showed that a homogeneity in ulcer risks over the age strata exists. Although the relative frequencies of the DU and GU cases were very dissimilar in young and old age groups of the present series (Table 3) , the estimated relative risks of coexisting ulcer did not show, in any of the categories of gastritis, any clear trends or heterogeneity by age (Table 4- 8) , suggesting that chronic gastritis per se is similarly associated with ulcer disease in general. This may further indicate that the DU particularly affects subjects in the early stages of the gastritic progression, whereas GU is more likely to affect subjects in advanced and later phases of this process. This view is supported by the present observations that the risk of coexisting GU, but not of DU, tends to increase with an increase in grade of the antral gastritis, and that the risk of coexisting DU in particular tends to decrease with an increase in grade of the body gastritis. Higher mean and median ages of GU patients compared with those of DU patients may also support this conclusion.
The present study is based on cross section analysis of consecutive routine diagnostic outpatient endoscopies. The biopsy specimens were interpreted by one pathologist but the endoscopies were performed by several endoscopists. This may cause some variability in site of the biopsy specimens from the stomach. This bias, however, probably affects ulcer patients and controls, and possibly is of minor significance. Some more serious biases may, however, emerge from obvious differences in the nature of gastritis in ulcer patients and controls. A limited number of biopsy specimens may in histology overemphasise the grade of gastritis in severely patchy lesions as often is the case in gastritis in ulcer patients, in contrast with non-ulcer controls in whom gastritis is more commonly diffuse. An underestimation of the risks may, on the other hand, emerge by inclusion of all ulcer patients into the analysis -for example, ulcer patients with significant NSAID ingestion may increase the proportion of cases with histologically normal stomach among the ulcer patients, thus again decreasing the estimated risks of ulcer in subjects with gastritis.
In spite of the above reservations and threatening biases, the present results may have some practical implications: a coexisting active peptic ulcer disease, either duodenal or gastric, might be improbable and rare if the patient has histologically normal stomach or advanced atrophic gastritis in gastric body. On the other hand, the ulcer disease may be possible if a clear cut antral gastritis is present, and if this gastritis is accompanied by non-atrophic gastric body mucosa.
The cumulative risk of active ulcer may follow these similar guidelines, presuming that gastritis is not a simple result from ulcer itself. Thus, the risk of coexisting ulcer, the short term cumulative risk of active peptic ulcer could be very low in subjects in whom the stomach is histologically normal, but considerable if the subject has chronic antral gastritis. As the mean annual transition risk of a subject to move from normal to a pool of subjects with superficial gastritis, or further from the superficial gastritis pool to a pool of subjects with atrophic gastritis, is between 1 and 2% of the general population,'7 it would be rather improbable that a person would contract gastritis and subsequent DU or GU within the next few years if his/her stomach is now histologically normal.
More positive conclusions on cumulative ulcer risks can be suggested if atrophic gastritis is present in the gastric body. Because the body gastritis is an irreversible lesion,'7 the cumulative, even a late risk of peptic ulcer, and of DU in particular, would be low or even non-existent if a clear cut advanced atrophic gastritis is present in the gastric body.
The 
